Osteogenic tumors of bone

Seminars in Diagnostic Pathology

Volumn 31, Issue 1, 2014, Pages 21-29

  Green, Jeffery T ^a   Mills, Anne M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Bone; Osteoblastoma; Osteoid osteoma; Steosarcoma

Indexed keywords

IMATINIB;

ABLATION THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CHONDROBLASTOMA; CLEAR CELL CHONDROSARCOMA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FIBROBLASTIC OSTEOSARCOMA; HIGH GRADE SURFACE OSTEOSARCOMA; HISTOPATHOLOGY; HUMAN; INCIDENCE; JUXTACORTICAL OSTEOSARCOMA; LOW GRADE CENTRAL OSTEOSARCOMA; MOLECULAR PATHOLOGY; OSTEOBLASTOMA; OSTEOID OSTEOMA; OSTEOSARCOMA; PAGET OSTEOSARCOMA; POSTRADIATION OSTEOSARCOMA; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SMALL CELL OSTEOSARCOMA; SURVIVAL RATE; SYMPTOMATOLOGY; TELANGIECTATIC OSTEOSARCOMA;

BONE; OSTEOBLASTOMA; OSTEOID OSTEOMA; STEOSARCOMA;

BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEOPLASM GRADING; OSTEOBLASTOMA; OSTEOMA, OSTEOID; OSTEOSARCOMA;

EID: 84896965130     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2014.01.001     Document Type: Article

References (45)

1. Dorfman H.D., Weiss S.W. Borderline osteoblastic tumors: problems in the differential diagnosis of aggressive osteoblastoma and low-grade osteosarcoma. Semin Diagn Pathol 1984, 1:215-234.
2. Kunze E., Enderle A., Radig K., et al. Aggressive osteoblastoma with focal malignant transformation and development of pulmonary metastases: a case report with review of the literature. Gen Diagn Pathol 1996, 141(5-6):377-392.
3. Baker A.C., Rezeanu L., Klein M.J., et al. Aggressive osteoblastoma: a case report involving a unique chromosomal aberration. Int J Surg Pathol 2010, 18(3):219-224.
4. World Health Organization Classifications of Tumors. Pathology & Genetics of Tumors of Soft Tissue and Bone 2002, IARC Press, Lyon. C.M. Fletcher, K.K. Unni, F. Mertens (Eds.).
5. Hauben E.l., Weeden S, Pringle J., et al. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study of 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer 2002, 28:1218-1225.
6. Biegel J.A., Zhou J.Y., Emanel B.S. Complex karyotypes in a series of pediatric osteosarcomas. Cancer Genet Cytogenet 1989, 38:89-100.
7. Bridge J.A., Nelson M., McComb E., et al. Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. Cancer Genet Cytogenet 1997, 95:74-87.
8. Fletcher J.A., Gebhardt M.C., Kozakewich H.P. Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double minute chromosomes. Cancer Genet Cytogenet 1994, 77:81-88.
9. Mertens F., Larramedy M., Gusstavson A., et al. Radiation-associated sarcomas are characterized by complex karyotypes with frequent rearrangements of chromosome arm 3p. Cancer Genet Cytogenet 2000, 116:89-96.
10. Tarkkanen M., Kaipainen A., Karaharju E., et al. Cytogenetic study of 249 consecutive patients examined for a bone tumor. Cancer Genet Cytogenet 1993, 68:1-21.
11. Berner J.M., Forus A., Elkahloun A., et al. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosomes Cancer 1996, 17:254-259.
12. Forus A., Florenes V.A., Maelandsmo G., et al. 12q13-14 amplification in human sarcomas without MDM2 include CDK4, SAS, and GADD153/CHOP. Cancer Genet Cytogenet 1994, 77. (200-200).
13. Nguyen A., Lasthaus C., Guerin E., et al. Role of topoisomerases in pediatric high grade osteosarcomas: TOP2A gene is one of the unique molecular biomarkers of chemoresponse. Cancer 2013, 5(2):662-675.
14. Zhang K., Zhang Y., Zhu H., et al. High expression of MACC1 predicts poor prognosis in patients with osteosarcoma. Tumour Biol 2013, [E-publication ahead of print].
15. Ferracini R., Di Renzo M.F., Scotlandi K., et al. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 1995, 10:739-740.
16. Rong S., Jeffers M., Resau J.H., et al. Met expression and sarcoma tumorigenicity. Cancer Res 1993, 53:5355-5360.
17. Kruzelock R.P., Murphy E.C., Strong L.C., et al. Localization of a novel tumor suppressor locus on human chromosome 3q important in osteosarcoma tumorigenesis. Cancer Res 1997, 57:106-107.
18. Lo W.W., Wunder J.S., Dickson B.C., et al. Involvement and targeted intervention of dysregulated hedgehog signaling in osteosarcoma. Cancer 2014, 120(4):537-547.
19. Bacci G., Picci P., Ferrari S., et al. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities: results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer 1993, 72:2337-3228.
20. Salinas-Souza C., De Oliveira R., Alves M.T. The metastatic behavior of osteosarcoma by gene expression and cytogenetic analysis. Hum Pathol 2013, 44(10):2188-2198.
21. Haibach H., Farrel C., Dittrich F.J. Neoplasms arising in Paget's disease of bone: a study of 82 cases. Am J Clin Pathol 1985, 83:594-600.
22. Wick M.R., Siegal G.P., Unni K.K., et al. Sarcomas of the bone complicating osteitis deformans (Paget's disease): fifty years' experience. Am J Surg Pathol 1981, 5:47-59.
23. Deyrup A.T., Montag A.G., Inwards C.Y., et al. Sarcomas arising in Paget disease of bone: a clinicopathologic analysis of 70 cases. Arch Pathol Lab Med 2007, 131:942-946.
24. Huvos A.G., Sundaresan N., Bretsky S.K., et al. Osteogenic sarcoma of the skull. A clinicopathologic study of 19 patients. Cancer 1985, 56:1214-1221.
25. Henderson T.O., Rajaraman P., Stovall M., et al. Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study. Int J Radiat Oncol Biol Phys 2012, 84(1):224-230.
26. Mertens F., Mandahl N., Orndal C., et al. Cytogenetic findings in 33 osteosarcomas. Int J Cancer 1993, 55:44-50.
27. Komdeur R., Hoekstra H.J., Molenaar W.M., et al. Clinicopathologic assessment of postradiation sarcomas: KIT as a potential treatment target. Clin Cancer Res 2003, 9:2926-2932.
28. Roessner A., Radig K., Schneider-Stock R., et al. Genetic instability in osteoblastic tumors of the skeletal system. Pathol Res Pract 1998, 194:669-677.
29. Martin S.E., Dwyer A., Kissane J.M., et al. Small-cell osteosarcoma. Cancer 1982, 50:990-996.
30. Nakajima H., Sim F.H., Bond J.R., et al. Small cell osteosarcoma of the bone. Review of 72 cases. Cancer 1997, 79:2095-2106.
31. Edeiken J., Raymond A.K., Ayala A.G., et al. Small cell osteosarcoma. Skeletal Radiol 1987, 16:621-628.
32. Devaney D.M., Vinh T.N., Sweet D.E. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations. Hum Pathol 1993, 23:1211-1225.
33. Endo M., Yoshida T., Yamamoto H., et al. Low-grade central osteosarcoma arising from bone infarct. Hum Pathol 2013, 44(6):1184-1189.
34. Bonar S.F. Central low-grade osteosarcoma: a diagnostic challenge. Skeletal Radiol 2012, 41:365-367.
35. Malhas A.M., Sumathi V.P., James S.L., et al. Low-grade central osteosarcoma: a difficult condition to diagnose. Sarcoma 2012, [E-publication ahead of print].
36. Hayashi K., Tsuchiya H., Yamamoto N., et al. Diagnosis and treatment of low-grade osteosarcoma: experience with nine cases. Int J Clin Oncol 2013, [E-publication ahead of print].
37. Dujardin F., Binh M.B., Bouvier C., et al. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol 2011, 24(5):624-637.
38. Okada K., Franssica F.J., Sim F.H., et al. Parosteal osteosarcoma. A clinicopathological study of 46 cases. Cancer 1994, 85:1044-1054.
39. Duhamel L.A.E., Ye H., Halai D., et al. Frequency of mouse double minute 2 (MDM2) and mouse double minute 4 (MDM4) amplification in parosteal and conventional osteosarcoma subtypes. Histopathology 2012, 60(2):357-359.
40. Gamberi G., Ragazzini P., Benassi M.S., et al. Analysis of 12q13-15 genes in parosteal osteosarcoma. Clin Orthop Relat Res 2000, 377:195-204.
41. Gisselsson D., Höglund M., Mertens F., et al. Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization. Genes Chromosomes Cancer 1998, 23:203-212.
42. Gisselsson D., Pålsson E., Höglund M., et al. Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma. Genes Chromosomes Cancer 2002, 33:133-140.
43. Murphey M.D., Jelinek J.S., Temple H.T., et al. Imaging of periosteal osteosarcoma: radiologic-pathologic comparison. Radiology 2004, 233(1):129-138.
44. Robertson N.J., Newman P.L. Periosteal osteosarcoma of the cranium. Ann Diagn Pathol 2000, 4(5):300-302.
45. Staals E.L., Bacchini P., Bertoni F. High-grade surface osteosarcoma: a review of 25 cases from the Rizzoli Institute. Cancer 2008, 112(7):1592-1599.